These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 10652224)
1. Ligation of the T cell receptor complex results in phosphorylation of Smad2 in T lymphocytes. Mamura M; Nakao A; Goto D; Kato M; Saito Y; Iwamoto I Biochem Biophys Res Commun; 2000 Feb; 268(1):124-7. PubMed ID: 10652224 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis. Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149 [TBL] [Abstract][Full Text] [Related]
3. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. Brown JD; DiChiara MR; Anderson KR; Gimbrone MA; Topper JN J Biol Chem; 1999 Mar; 274(13):8797-805. PubMed ID: 10085121 [TBL] [Abstract][Full Text] [Related]
4. Resistance to TGF-beta1-mediated growth inhibition correlates with sustained Smad2 phosphorylation in primary murine splenocytes. Feldmann K; Sebald W; Knaus P Eur J Immunol; 2002 May; 32(5):1393-402. PubMed ID: 11981827 [TBL] [Abstract][Full Text] [Related]
5. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Hayashida T; Decaestecker M; Schnaper HW FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291 [TBL] [Abstract][Full Text] [Related]
6. TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS. Koschmieder S; Hofmann WK; Kunert J; Wagner S; Ballas K; Seipelt G; Hoelzer D; Ottmann OG; Kalina U Leukemia; 2001 Jun; 15(6):942-9. PubMed ID: 11417481 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966 [TBL] [Abstract][Full Text] [Related]
8. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. Simeone DM; Zhang L; Graziano K; Nicke B; Pham T; Schaefer C; Logsdon CD Am J Physiol Cell Physiol; 2001 Jul; 281(1):C311-9. PubMed ID: 11401854 [TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
10. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. McKarns SC; Schwartz RH; Kaminski NE J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. Osman A; Niles EG; LoVerde PT J Biol Chem; 2001 Mar; 276(13):10072-82. PubMed ID: 11152451 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284 [TBL] [Abstract][Full Text] [Related]
14. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Pessah M; Prunier C; Marais J; Ferrand N; Mazars A; Lallemand F; Gauthier JM; Atfi A Proc Natl Acad Sci U S A; 2001 May; 98(11):6198-203. PubMed ID: 11371641 [TBL] [Abstract][Full Text] [Related]
15. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related]
16. Signaling via the T cell antigen receptor induces phosphorylation of Stat1 on serine 727. Gamero AM; Larner AC J Biol Chem; 2000 Jun; 275(22):16574-8. PubMed ID: 10748192 [TBL] [Abstract][Full Text] [Related]
17. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. Feng XH; Lin X; Derynck R EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220 [TBL] [Abstract][Full Text] [Related]
18. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. Kawase T; Okuda K; Yoshie H; Burns DM J Periodontal Res; 2002 Aug; 37(4):255-62. PubMed ID: 12200968 [TBL] [Abstract][Full Text] [Related]
19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
20. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]